KRAS and non-small cell lung carcinoma: He published an update about the detection of KRAS mutations in NSCLC, including signalling pathways, epidemiology, prognosis, progress in drug, resistance mechanisms, molecular testing, rendering a broad perspective for the detection and treatment among KRAS-mutant NSCLC patients (30).